Merrill Lynch may have been one of the first mainstream investment firms to release a report on the burgeoning legal marijuana market back in 2015, but more have followed, including the Edward Jones marijuana report that recently entered the fray.
Tag Archives: Merrill Lynch
LONDON, May 4, 2016 /Weed Wire/ — GW Pharmaceuticals announced that Justin Gover, GW’s Chief Executive Officer, will present at the Bank of America Merrill Lynch 2016 Healthcare Conference on Tuesday, May 10, 2016, at 9:20 a.m. (PDT) at the Encore at the Wynn Las Vegas, Las Vegas, Nev.
No one supposes that the core business of Bank of America, Merrill Lynch’s parent company, is social justice. But social investing is not a new idea.
Cannabis stocks struggled on this Friday trading session. Volumes were low, profit taking in recent high flyers, and poor trading behavior to cap out the week.